Next-Gen Biosafety Masterclass

Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use

SEPTEMBER 10, 2026 in Paris (France)

PathoQuest is pleased to announce the upcoming Next-Gen Biosafety Masterclass: "Next Generation Sequencing (NGS) in Biosafety Testing: From Regulation to Routine Use."

🗓️ September 10, 2026
🕘 8:30 AM – 5:30 PM CET
📍 11 Rue Watt, BioPark, Bâtiment B, 75 013 Paris, France
👤 IN-PERSON

Our preliminary agenda is available:

  • Welcome & strategic context & Presentation of the agenda
    Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest
    Horst Ruppach – Executive Director Scientific and Portfolio, Global Biologics, Charles River Laboratories
  • European Regulations on detection of viral adventitious agents by next generation sequencing
    Johannes Bluemel – Head of Viral Safety Section, Paul-Ehrlich-Institut
  • Global overview of implementation and regulatory acceptance of NGS for vaccines safety testing
    Laura Viviani – Founder and consultant at SciEthiQ, consultant for Animal Free Safety Assessment Collaboration
  • NGS in Viral Safety: From Comparison of Methods to Qualification
    Florence Suavet – Chief Technical Officer, PathoQuest
    Marc Eloit – Founder & Scientific Advisor, PathoQuest
  • Characterization of starting materials for the production of Virus Therapeutics by Next Generation Sequencing (NGS)
    Michael Ruffing – Global Development CMC Biologicals, Boehringer Ingelheim
  • Integrated Use of Viromic and Transcriptomic NGS for Adventitious Virus Testing
    Jens Modrof – Director Operations, Global Pathogen Safety, Takeda
  • Upcoming news on NGS / Title TBC
    Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest
    Horst Ruppach – Executive Director Scientific and Portfolio, Global Biologics,Charles River Laboratories
  • The Power and Challenges of NGS in Viral Vector Identity Assays
    Nadia Avenier – Head of Analytical Expertise Center, Yposkesi / an SK pharmteco company
  • Industry Speaker Title TBC
    Carine Logvinoff – Virology Global Analytical Expert, Sanofi
  • Adoption of NGS for Viral Safety Testing in Exosome Manufacturing
    Huilan Lin – Principal Scientist, Capricor Therapeutics
  • Ask the Experts – Interactive Session
    All speakers
  • Closing Remarks & Networking Cocktail
    Colette Côté – Chief Scientific & Portfolio Officer, PathoQuest

This agenda is preliminary and subject to refinement.

👉 Free registration is now open.

Seating is limited. Secure your place today.

REGISTER NOW FOR FREE